Calculating global risk: the key to intervention
Open Access
- 1 July 2005
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
- Vol. 7 (suppl_F) , F9-F14
- https://doi.org/10.1093/eurheartj/sui037
Abstract
The assessment of overall cardiovascular risk is a valuable and accepted means of identifying patients who are likely to benefit most from intervention to control individual cardiovascular risk. A straightforward and accurate means of calculating overall cardiovascular risk has been derived from the PROspective CArdiovascular Münster (PROCAM) Study, a large observational cohort study. The PROCAM risk calculator has several advantages over other risk calculators. For example, the algorithm derived from the Framingham study consistently and markedly overestimates the risk of myocardial infarction in the PROCAM population, or in a German cohort within the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) Study, administered by the World Health Organization. In addition, the PROCAM risk calculator incorporates a broader range of commonly measured diagnostic parameters than the Framingham risk calculator. The multivariate Cox proportional hazards model that supports the PROCAM risk calculator has also provided valuable information on the principal driving forces behind atherosclerotic cardiovascular disease, with age, the level of LDL-cholesterol, smoking, the level of HDL-cholesterol, systolic blood pressure, family history of myocardial infarction, diagnosis of diabetes, and triglycerides all making significant contributions. As in other studies, low HDL-cholesterol emerged as a significant and independent risk factor for coronary disease, providing support for strategies aimed at correcting low HDL-cholesterol in addition to those aimed at reducing elevated levels of LDL-cholesterol.Keywords
This publication has 21 references indexed in Scilit:
- European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)European Heart Journal, 2003
- Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) StudyCirculation, 2002
- Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular riskPublished by Elsevier ,2001
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Incidence and Risk Factors for Stroke in an Occupational CohortStroke, 1998
- Epidemiology of triglycerides: A view from FraminghamThe American Journal of Cardiology, 1992
- Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)The American Journal of Cardiology, 1992
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989
- Hypertension, antihypertensive treatment, and sudden coronary death. The Framingham Study.Hypertension, 1988
- Risk Factors in Coronary Heart Disease: An Evaluation of Several Serum Lipids as Predictors of Coronary Heart Disease: The Framingham StudyAnnals of Internal Medicine, 1964